S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.38 (-1.47%)
BABA   72.14 (-0.26%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+10.74%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.51%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.38 (-1.47%)
BABA   72.14 (-0.26%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+10.74%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.51%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.38 (-1.47%)
BABA   72.14 (-0.26%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+10.74%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.51%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.38 (-1.47%)
BABA   72.14 (-0.26%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+10.74%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.51%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)

GAN Stock Price, News & Analysis (NASDAQ:GAN)

$1.56
+0.02 (+1.30%)
(As of 05:17 PM ET)
Compare
Today's Range
$1.53
$1.57
50-Day Range
$0.83
$1.66
52-Week Range
$0.83
$2.49
Volume
201,800 shs
Average Volume
414,308 shs
Market Capitalization
$69.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50

GAN MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
60.3% Upside
$2.50 Price Target
Short Interest
Healthy
1.25% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.15mentions of GAN in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.67 out of 5 stars

Computer And Technology Sector

483rd out of 595 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

30th out of 41 stocks


GAN stock logo

About GAN Stock (NASDAQ:GAN)

GAN Limited operates as a business-to-business (B2B) supplier of enterprise software-as-a-service solutions to online casino gaming and sports betting applications in the United States, Europe, Latin America, and internationally. The company operates in two segments, B2B and Business-to-Consumer (B2C). It offers and licenses GameSTACK, an internet gaming platform that provides turnkey technology solution for regulated real-money internet gambling, online sports betting, and simulated gaming. The company also offers online sports betting, online casino game, and peer-to-peer poker services through its coolbet.com website, as well as a range of development, marketing, and customer support services designed to fast-track deployments and provide ongoing operational support for its software systems. It serves regional operators and individual tribal casino operators. The company was incorporated in 1999 and is headquartered in Irvine, California.

GAN Stock Price History

GAN Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Contrasting GAN (NASDAQ:GAN) & Cardlytics (NASDAQ:CDLX)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Insider Spends AU$110k Buying More Shares In Fatfish Group
See More Headlines
Receive GAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GAN and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2023
Today
12/08/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
4/04/2024

Industry, Sector and Symbol

Industry
Computer programming, data processing, & other computer related
Sub-Industry
N/A
Current Symbol
NASDAQ:GAN
Fax
N/A
Employees
701
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.50
High Stock Price Target
$2.50
Low Stock Price Target
$2.50
Potential Upside/Downside
+62.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-197,500,000.00
Net Margins
-127.37%
Pretax Margin
-124.56%

Debt

Sales & Book Value

Annual Sales
$135.65 million
Book Value
$0.49 per share

Miscellaneous

Free Float
40,901,000
Market Cap
$68.84 million
Optionable
Optionable
Beta
2.04
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Seamus M. McGillMr. Seamus M. McGill (Age 72)
    Interim CEO & Chairman
    Comp: $469.7k
  • Mr. Jan Roos (Age 42)
    Chief Technology Officer
    Comp: $287.6k
  • Ms. Sylvia Tiscareno (Age 46)
    Chief Legal Officer & Corporate Secretary
    Comp: $375.1k
  • Mr. Brian Chang (Age 41)
    Interim Chief Financial Officer
  • Mr. Marcus Yoder
    Senior Vice President of Sales
  • Mr. Ervin Jarvlepp
    Chief Marketing Officer
  • Ms. Betty Wong
    Chief People Officer
  • Mr. Martin Smith (Age 56)
    Chief Data & Analytics Officer
  • Mr. Robert Jason Shore
    Vice President of North America Sportsbook Sales & Operations
  • Mr. Giuseppe Gardali (Age 41)
    President of B2B














GAN Stock Analysis - Frequently Asked Questions

Should I buy or sell GAN stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GAN in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GAN, but not buy additional shares or sell existing shares.
View GAN analyst ratings
or view top-rated stocks.

What is GAN's stock price target for 2024?

2 Wall Street research analysts have issued 12 month target prices for GAN's shares. Their GAN share price targets range from $2.50 to $2.50. On average, they expect the company's stock price to reach $2.50 in the next twelve months. This suggests a possible upside of 60.3% from the stock's current price.
View analysts price targets for GAN
or view top-rated stocks among Wall Street analysts.

How have GAN shares performed in 2023?

GAN's stock was trading at $1.50 at the beginning of 2023. Since then, GAN stock has increased by 4.0% and is now trading at $1.56.
View the best growth stocks for 2023 here
.

Are investors shorting GAN?

GAN saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 559,500 shares, a drop of 23.7% from the October 31st total of 733,300 shares. Based on an average daily volume of 770,800 shares, the days-to-cover ratio is presently 0.7 days.
View GAN's Short Interest
.

When is GAN's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 4th 2024.
View our GAN earnings forecast
.

How were GAN's earnings last quarter?

GAN Limited (NASDAQ:GAN) posted its quarterly earnings results on Thursday, November, 9th. The company reported ($0.18) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.02. The firm earned $29.82 million during the quarter. GAN had a negative trailing twelve-month return on equity of 188.72% and a negative net margin of 127.37%.

What ETF holds GAN's stock ?

Roundhill Sports Betting & iGaming ETF holds 233,402 shares of GAN stock, representing 0.36% of its portfolio.

What is Dermot Smurfit's approval rating as GAN's CEO?

5 employees have rated GAN Chief Executive Officer Dermot Smurfit on Glassdoor.com. Dermot Smurfit has an approval rating of 63% among the company's employees. This puts Dermot Smurfit in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of GAN own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GAN investors own include Altice USA (ATUS), Intel (INTC), Altria Group (MO), PG&E (PCG), AAR (AIR), Aptiv (APTV), Alteryx (AYX), Cogent Communications (CCOI), FTI Consulting (FCN) and Hill-Rom (HRC).

When did GAN IPO?

(GAN) raised $48 million in an IPO on Tuesday, May 5th 2020. The company issued 6,400,000 shares at a price of $6.50-$8.50 per share. B. Riley FBR served as the underwriter for the IPO and Macquarie Capital was co-manager.

Who are GAN's major shareholders?

GAN's stock is owned by a number of institutional and retail investors. Top institutional investors include River & Mercantile Asset Management LLP (1.80%), GSA Capital Partners LLP (0.72%), Ingalls & Snyder LLC (0.15%), Integrated Wealth Concepts LLC (0.09%), Gamco Investors INC. ET AL (0.07%) and Group One Trading L.P. (0.00%). Insiders that own company stock include David Goldberg, Dermot S Smurfit, Glenn Anders Karlsen, Jeffrey Bruce Berman, Karen Flores, Michael Jr Smurfit, Seamus M Mcgill, Seamus M Mcgill and Simon Knock.
View institutional ownership trends
.

How do I buy shares of GAN?

Shares of GAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:GAN) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -